ASX Release 13 November 2026 A$1.2 million R&D Tax Incentive refund received Highlights: • A$1.2 million R&D Tax Incentive refund received, further strengthening Nexsen’s cash position and supporting ongoing diagnostic development and commercialisation activities. • Further HK$750,000...
A$1.2 million R&D Tax Incentive refund received
Filed with ASX · · 2 pages · English
Summary by 6ix AI
Nexsen Limited has announced the receipt of a significant refund under the Australian Government’s R&D Tax Incentive program, which will enhance its cash position and support ongoing development activities. The refund is linked to the company's eligible research and development expenditures, aimed at advancing its portfolio of rapid point-of-care diagnostics. Additionally, Nexsen expects to receive further funding under a previously awarded grant to support its initiatives in Hong Kong.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Earlier from Nexsen
- Results of Meeting
- Nexsen advances kidney diagnostics program
- Co Secretary Appoint/Resign and Change of Registered Address
- ISO 13485 Certification brings StrepSure closer to market
- Quarterly Report - Q1 FY27
Later from Nexsen
All Nexsen news releasesFollow Nexsen into a list and get an email when it puts out news.
Follow Nexsen